Showing results (31-40 of 186) with videos related to

Sort By:
Pageof 19
Cancer Treatment Reviews|October 11, 2011
Endothelial vascular toxicity from chemotherapeutic agents: preclinical evidence and clinical implicationsAspasia Soultati, Giannis Mountzios, Chrysoula Avgerinou, et al.
BMC Cancer|March 2, 2006
Prognostic significance of HER3 and HER4 protein expression in colorectal adenocarcinomasPanteleimon Kountourakis, Kitty Pavlakis, Amanda Psyrri, et al.
Anticancer Research|July 11, 2006
Dermatomyositis associated with breast cancerDimitrios Pectasides, Maria Koumpou, Asimina Gaglia, et al.
Critical Reviews in Oncology/Hematology|September 14, 2010
Developments in the systemic treatment of endometrial cancerGiannis Mountzios, Dimitrios Pectasides, Evangelos Bournakis, et al.
Cancer Journal (Sudbury, Mass.)|June 29, 2006
Clinicopathologic significance of EGFR and Her-2/neu in colorectal adenocarcinomasPanteleimon Kountourakis, Kitty Pavlakis, Amanda Psyrri, et al.
Anticancer Research|February 11, 2015
Predictive biomarkers to chemotherapy in patients with advanced melanoma receiving the combination of cisplatin--vinblastine--temozolomide (PVT) as first-line treatment: a study of the Hellenic Cooperative Oncology Group (HECOG)Helena Linardou, George Pentheroudakis, Ioannis Varthalitis, et al.
Oncology Letters|July 12, 2012
Correlation of CYP1A1, GSTP1 and GSTM1 gene polymorphisms and lung cancer risk among smokersKyriaki Pliarchopoulou, Gerasimos Voutsinas, George Papaxoinis, et al.
Gynecologic Oncology|July 8, 2008
Combination chemotherapy with carboplatin, paclitaxel and pegylated liposomal doxorubicin for advanced or recurrent carcinosarcoma of the uterus: clinical experience of a single institutionDimitrios Pectasides, Eirini Pectasides, George Papaxoinis, et al.
The Breast Journal|June 9, 2023
Impact of CDK4/6 Inhibitors on Aromatase Inhibitor-Associated Musculoskeletal Syndrome (AIMSS) in the Adjuvant SettingEfthymia Skafida, Angeliki Andrikopoulou, Evangelos Terpos, et al.
Anticancer Research|December 12, 2003
Irinotecan and gemcitabine in patients with advanced non-small cell lung cancer, previously treated with cisplatin-based chemotherapy. A phase II studyDimitrios Pectasides, Nikolaos Mylonakis, Dimitrios Farmakis, et al.
Pageof 19